The evolving role of autologous and allogeneic stem cell transplantation in follicular lymphoma

Blood Reviews
Koen van Besien

Abstract

Treatment options for follicular lymphoma have expanded dramatically. The most important relate to the introduction of monoclonal antibodies and the completion of important studies regarding autologous and allogeneic transplantation. The EBMTR-sponsored "CUP Trial" (conventional Chemotherapy, Unpurged autograft, Purged autograft), demonstrated that for patients under age 60 years with recurrent chemotherapy-sensitive disease, autologous stem cell transplantation (ASCT) provides a survival benefit over conventional therapy. Three randomized studies demonstrated that consolidation with autologous transplantation in first remission leads to improvement in progression free survival and perhaps in overall survival, but possibly with an increased risk for secondary MDS. Novel approaches involve the incorporation of rituximab as an in-vivo purging agent or as post-transplant therapy, and the use of radiolabelled monoclonals in the conditioning regimens. Allogeneic stem cell transplantation (alloSCT) has become a more effective option but continues to have a high TRM. Reduced-intensity alloSCT procedures now are being performed at an increasing rate and may have advantages in particular situations. A CIBMTR analysis unfortunately did n...Continue Reading

References

Jan 1, 1995·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·P W JohnsonT A Lister
Feb 1, 1997·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·P J BiermanJ O Armitage
Feb 2, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J ApostolidisA Z Rohatiner
Dec 29, 2000·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·I W FlinnR F Ambinder
Feb 24, 2001·Annals of Oncology : Official Journal of the European Society for Medical Oncology·P BriceUNKNOWN Groupe d'Etude des Lymphomes de l'Adulte (GELA)
May 2, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D M LillingtonA Z Rohatiner
Jun 13, 2001·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·T M CaoK E Stockerl-Goldstein
Sep 10, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Philip J BiermanUNKNOWN Lymphoma Working Committee of the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow
Oct 1, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Harry C SchoutenGunnar Kvalheim
May 19, 2004·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Koen Van BesienRichard Champlin
Nov 10, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Julie M VoseJames O Armitage
Nov 16, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Amy L HoerrHanna J Khoury
Feb 3, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A Z S RohatinerT A Lister
Mar 2, 2005·Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis·Emma Morris, Stephen Mackinnon
Sep 2, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Chadi Nabhan
Sep 2, 2005·Bone Marrow Transplantation·A S Artz
Oct 19, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Richard I FisherThomas P Miller

❮ Previous
Next ❯

Citations

Jun 30, 2009·Journal of Immunotherapy·James N KochenderferSteven A Rosenberg
Nov 19, 2010·Expert Review of Hematology·Stefano LuminariMassimo Federico
Dec 12, 2012·Autoimmunity Reviews·C TarellaA Cignetti
Nov 9, 2011·Clinical Lymphoma, Myeloma & Leukemia·Peter McLaughlin
Apr 14, 2009·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Koen van BesienParameswaran N Hari
Mar 18, 2008·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Philippe ArmandEdwin P Alyea
Dec 2, 2014·Bone Marrow Transplantation·S HongM C Pasquini
Apr 5, 2016·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Christopher R FlowersEdmund K Waller
May 21, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Corrado TarellaAlessandro Rambaldi
Dec 22, 2006·PloS One·Hendrik P J BonariusNiek de Vries
Jul 1, 2008·The Oncologist·Franz BucheggerNicolas Ketterer

❮ Previous
Next ❯

Related Concepts

Related Feeds

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.